EUS RFA for Pancreatic Cancer
Phase 1
15
about 5 years
18+
1 site in NY
What this study is about
This trial is testing the safety and tolerability of chemotherapy plus endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) in people with pancreatic cancer who are not candidates for surgery. The treatment uses a device to deliver heat to cancerous cells.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Chemotherapy
- 2.Use Endoscopic Ultrasound-Guided Radiofrequency Ablation (EUS-RFA)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Primary: Percentage of Participants who Complete Therapy without Grade III-IV Adverse Events (AEs) as Assessed by CTCAE v. 5.0
Secondary: Disease-Free Survival from Diagnosis, Disease-Free Survival from First Study Procedure, Overall Survival From Diagnosis
Oncology